Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus
- Resource Type
- Article
- Source
- In
Diabetes & Metabolic Syndrome: Clinical Research & Reviews November-December 2020 14(6):1913-1919 - Subject
- Language
- ISSN
- 1871-4021